CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 77.3% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Close

Trade Vir Biotechnology VIR

Sell
 Buy

VirBiotechnology live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

News

Webhose 2025 Apr 27, 09:32

Syon Capital LLC Makes New $77,000 Investment in Vir Biotechnology, Inc. (NASDAQ:VIR)

Vir Biotechnology Inc
Webhose 2025 Apr 26, 07:45

Vir Biotechnology (VIR) to Release Earnings on Thursday

Vir Biotechnology Inc
Webhose 2025 Apr 25, 10:23

Vir Biotechnology, Inc. (NASDAQ:VIR) Given Average Recommendation of "Moderate Buy" by Analysts

Vir Biotechnology Inc
Webhose 2025 Apr 23, 17:58

Vir Biotechnology (NASDAQ:VIR) Shares Up 5.5% - Here's What Happened

Vir Biotechnology Inc
Webhose 2025 Apr 20, 09:26

Vir Biotechnology, Inc. (NASDAQ:VIR) Short Interest Up 28.3% in March

Vir Biotechnology Inc
Webhose 2025 Apr 20, 08:36

Walleye Capital LLC Increases Stock Position in Vir Biotechnology, Inc. (NASDAQ:VIR)

Vir Biotechnology Inc
Webhose 2025 Apr 20, 07:52

Renaissance Technologies LLC Buys 55,300 Shares of Vir Biotechnology, Inc. (NASDAQ:VIR)

Vir Biotechnology Inc
Webhose 2025 Apr 10, 05:00

New Mpro inhibitors revealed in Vir Biotechnology patent | BioWorld

Vir Biotechnology Inc
Webhose 2025 Apr 09, 16:06

Vir Biotechnology (NASDAQ:VIR) Sets New 1-Year Low - Here's Why

Vir Biotechnology Inc
Webhose 2025 Apr 09, 13:43

Vir Biotechnology, Inc. (VIR): Among Stocks Under $10 that Will Triple

Vir Biotechnology Inc
Webhose 2025 Apr 09, 11:13

ADAR1 Capital Management LLC Sells 255,118 Shares of Vir Biotechnology, Inc. (NASDAQ:VIR)

Vir Biotechnology Inc
Webhose 2025 Apr 09, 00:00

Hepatitis B Virus (HBV) Infection Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies | ABNewswire

Vir Biotechnology Inc
Webhose 2025 Apr 06, 08:03

Vir Biotechnology, Inc. (NASDAQ:VIR) CEO Sells $474,286.40 in Stock

Vir Biotechnology Inc
Webhose 2025 Apr 06, 07:35

Prudential Financial Inc. Sells 180,800 Shares of Vir Biotechnology, Inc. (NASDAQ:VIR)

Vir Biotechnology Inc
Webhose 2025 Mar 31, 13:42

Vir Biotechnology Insiders Sell US$1.3m Of Stock, Possibly Signalling Caution

Vir Biotechnology Inc
Webhose 2025 Mar 31, 00:00

Authority Investment Dhabi Abu - Insider Monkey

Vir Biotechnology Inc
Webhose 2025 Mar 30, 10:13

Vir Biotechnology, Inc. (NASDAQ:VIR) Receives Consensus Rating of "Moderate Buy" from Analysts

Vir Biotechnology Inc
Webhose 2025 Mar 30, 08:59

Artisan Partners Limited Partnership Makes New Investment in Vir Biotechnology, Inc. (NASDAQ:VIR)

Vir Biotechnology Inc
Webhose 2025 Mar 30, 08:26

WINTON GROUP Ltd Reduces Holdings in Vir Biotechnology, Inc. (NASDAQ:VIR)

Vir Biotechnology Inc

VirBiotechnology news

2025 Business Trend and Market
Christine Voong 2025 Feb 13, 21:36

Business Trends 2025: Key Insights Shaping the Future of Global Markets

Latest news

Show more
Frances Wang 2025 Apr 27, 16:00

ETFs That Outperform the S&P 500: ARKK, VGT, IWF, XBI

ETFs
Frances Wang 2025 Apr 27, 16:00

Forex Market Today: Analyzing Seasonal Patterns in Forex Market Trends

Forex
Frances Wang 2025 Apr 27, 16:00

Dow Jones today: Major Indexes Rise as Trump Signals Softer Trade Stance

Stocks
Tommy Yap 2025 Apr 27, 16:00

Morning Note: Gold Dips on Dollar Strength, ECB Eyes Rate Cut, Japan Denies FX Pressure

Morning Note Commodities Forex
Tommy Yap 2025 Apr 26, 21:00

Week Ahead: Canada Election and U.S. NFP in Focus

Forex Indices
Frances Wang 2025 Apr 24, 16:00

How will tariffs affect forex: EUR/USD pair weakens amid trade uncertainty

Forex
Frances Wang 2025 Apr 24, 16:00

Exchange Traded Funds News: Tech-Focused ETFs Gain Traction Amid AI Boom

ETFs
Tommy Yap 2025 Apr 24, 16:00

Morning Note: US-China Trade Deadlock; Nvidia's AI Leap; Canada Votes

Morning Note CAD Forex

Info

Spread

0.05

Spread (%)

0.8170 %

Leverage

1:5

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Market open

Monday

13:31 - 19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

868421888

Shares Outstanding

138064000

Earnings Date (Next)

0000-00-00

Div Yield

Ex-Dividend Date

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

-3.83

Learn more about this instrument

Vir Biotechnology Vir Biotechnology Inc
Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors.The company's preclinical candidates include those targeting influenza A and B, coronavirus disease 2019, respiratory syncytial virus (RSV) and human metapneumovirus (MPV), and human papillomavirus (HPV). It has grant agreements with Gates Foundation; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with MedImmune, LLC; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A, as well as license agreement with Sanofi for three clinical-stage masked T-cell engagers (TCEs) and exclusive use of the protease-cleavable masking platform for oncology and infectious diseases. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Frances Wang 2025 Apr 27, 16:00

Bond ETF Analysis: How Market Volatility Affects Bond ETF Performance

ETFs
Frances Wang 2025 Apr 27, 16:00

Commodity Market Today: Relationship Between Global Economies and Oil Prices

Commodities
Frances Wang 2025 Apr 27, 16:00

Cryptocurrency Price Fluctuations: Factors Influencing Cryptocurrency Trends

Crypto
Trustpilot